Canine Leishmania vaccine
US7794736B2 · kind B2 · utility
3Cited by
1References
13Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 19, 2007 |
| Grant date | Sep 14, 2010 |
| Priority date | — |
| Expiry date | Mar 9, 2028 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides vectors that contain and express in vivo Leishmania KMP11 or an epitope thereof that elicits an immune response in a dog against Leishmania, compositions comprising said vectors, methods of vaccination against Leishmania, and kits for use with such methods and compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.